8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant To Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) September 15, 2015

PSYCHEMEDICS CORPORATION

(Exact Name of Registrant As Specified In Its Charter)

Delaware	1-13738	58-1701987
(State or Other Jurisdiction	(Commission File Number)	(I.R.S. Employer
of  Incorporation)		Identification No.)

125 Nagog Park, Acton, Massachusetts	01720
(Address of Principal Executive Offices)	(Zip Code)

(978) 206-8220

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 15, 2015, the Board of Directors (the “Board”) of Psychemedics Corporation elected A. Clinton Allen as a director and as a member of the Audit, Compensation and Nominating Committees of the Board, all effective as of September 15, 2015. In connection with the election, the Board increased the number of directors constituting the Board from four to five.

Mr. Allen had previously served as Vice Chairman of the Company from 1990 to 2000 and Chairman from 2000 to 2002. He will join the Board as an independent member. Mr. Allen will be compensated, and will be eligible to participate in the Company’s compensation plans and arrangements, in the same manner as the Company’s other independent directors, as described in the Company’s proxy materials filed with the U.S. Securities and Exchange Commission.

ITEM 7.01 Regulation FD Disclosure.

The Company issued a press release on September 17, 2015 announcing the election of Mr. Allen. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.

ITEM 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.	Description
99.1	Press release dated September 17, 2015 of Psychemedics Corporation

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

	PSYCHEMEDICS CORPORATION
Dated: September 17, 2015	By:	/s/ Neil Lerner
		Neil Lerner, Vice President - Finance

EX-99.1

Exhibit 99.1

Psychemedics Corporation Expands Board Of Directors

A. Clinton Allen Rejoins Board

ACTON, Mass., Sept. 17, 2015 /PRNewswire/ -- Psychemedics Corporation's (PMD: NASDAQ) Board of Directors has voted to expand the Board to five members from the current four members. At the same time, the Board has voted to add Mr. A. Clinton Allen as the new Board member.

Mr. Allen had previously served as Vice-Chairman of the company from 1990 to 2000 and Chairman from 2000 to 2002. He will join the Board as an independent member. Mr. Allen is the Founder and President of the American Academy (College) of Corporate Directors, the premier Director education and credentialing organization in the United States. Mr. Allen also serves as Chairman of the Board of Collectors Universe, member of the board of Brooks Automation and is Lead Director of LKQ Corporation, a Fortune 500 Company.

Raymond C. Kubacki, Chairman and & CEO stated:

"Clint has maintained a continuing interest and commitment to our company's success. We are extremely pleased that he will be rejoining the Board and look forward to having his counsel, perspective and energy."

Psychemedics Corporation is the world's largest provider of hair testing for the detection of drugs of abuse. With its patented process, the Company serves thousands of U.S. and international clients, including over 10% of the Fortune 500 companies, for pre-employment and random drug testing. Major police departments, Federal Reserve Banks, schools, and other public entities also rely on our unique patented drug testing process. We strongly believe our drug testing method to be superior to any other product currently in use, including traditional urine testing and other hair testing methods.

The Psychemedics web site is www.psychemedics.com

Contact:	Neil Lerner
	Vice President of Finance
	(978) 206-8220
	Neill@psychemedics.com

Logo - http://photos.prnewswire.com/prnh/20111107/NE00639LOGO